{
  "success": true,
  "sourceFile": "input/Alexion_NCT04573309_Wilsons_SAP.pdf",
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33
  ],
  "modelUsed": "gemini-2.5-pro",
  "sapData": {
    "analysisPopulations": [
      {
        "id": "pop_1",
        "name": "Screened Set",
        "populationType": "Disposition",
        "instanceType": "AnalysisPopulation",
        "description": "The Screened Set will include all participants who signed an informed consent form (ICF).",
        "criteria": "Signed an informed consent form (ICF)"
      },
      {
        "id": "pop_2",
        "name": "Enrolled Set",
        "populationType": "Disposition",
        "instanceType": "AnalysisPopulation",
        "description": "The Enrolled Set will include all participants who were enrolled in the study.",
        "criteria": "Enrolled in the study"
      },
      {
        "id": "pop_3",
        "name": "Full Analysis Set",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "FA",
        "description": "The Full Analysis (FA) Set will include all participants who were enrolled and received at least 1 dose of study drug. The FA Set will be the primary population for all efficacy analyses.",
        "criteria": "Enrolled and received at least 1 dose of study drug"
      },
      {
        "id": "pop_4",
        "name": "Per Protocol Set",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "PP",
        "description": "The Per Protocol (PP) Set will include all participants in the FA Set who have no major protocol deviations that would impact the primary efficacy endpoint. The PP Set will be used for sensitivity analyses of the primary efficacy endpoint.",
        "criteria": "Participant is in the FA Set and has no major protocol deviations that would impact the primary efficacy endpoint"
      },
      {
        "id": "pop_5",
        "name": "Safety Set",
        "populationType": "Safety",
        "instanceType": "AnalysisPopulation",
        "description": "The Safety Set will include all participants who received at least 1 dose of study drug. The Safety Set will be the primary population for all safety analyses.",
        "criteria": "Received at least 1 dose of study drug"
      },
      {
        "id": "pop_6",
        "name": "Pharmacokinetic Analysis Set",
        "populationType": "Pharmacokinetic",
        "instanceType": "AnalysisPopulation",
        "label": "PK",
        "description": "The Pharmacokinetic (PK) Analysis Set will include all participants in the Safety Set who have sufficient plasma concentration data to derive at least 1 PK parameter. The PK Analysis Set will be used for all PK analyses.",
        "criteria": "Participant is in the Safety Set and has sufficient plasma concentration data to derive at least 1 PK parameter"
      },
      {
        "id": "pop_7",
        "name": "Pharmacodynamic Analysis Set",
        "populationType": "Pharmacodynamic",
        "instanceType": "AnalysisPopulation",
        "label": "PD",
        "description": "The Pharmacodynamic (PD) Analysis Set will include all participants in the Safety Set who have sufficient PD data to derive at least 1 PD parameter. The PD Analysis Set will be used for all PD analyses.",
        "criteria": "Participant is in the Safety Set and has sufficient PD data to derive at least 1 PD parameter"
      }
    ],
    "characteristics": [
      {
        "id": "char_1",
        "name": "Age",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Age in years, calculated as the integer part of (date of informed consent â€“ date of birth + 1)/365.25."
      },
      {
        "id": "char_2",
        "name": "Sex",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Sex of the participant."
      },
      {
        "id": "char_3",
        "name": "Race",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Race of the participant."
      },
      {
        "id": "char_4",
        "name": "Ethnicity",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Ethnicity of the participant."
      },
      {
        "id": "char_5",
        "name": "Duration of Wilson Disease",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Duration of Wilson Disease (WD) at baseline."
      },
      {
        "id": "char_6",
        "name": "Age at diagnosis of Wilson Disease",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Age at diagnosis of Wilson Disease (WD)."
      },
      {
        "id": "char_7",
        "name": "Weight",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Baseline weight in kg."
      },
      {
        "id": "char_8",
        "name": "Height",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Baseline height in cm."
      },
      {
        "id": "char_9",
        "name": "Body Mass Index (BMI)",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Baseline Body Mass Index (BMI) in kg/m2."
      },
      {
        "id": "char_10",
        "name": "Serum ceruloplasmin",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Baseline laboratory parameter for serum ceruloplasmin."
      },
      {
        "id": "char_11",
        "name": "Serum copper",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Baseline laboratory parameter for serum copper."
      },
      {
        "id": "char_12",
        "name": "24-hour urinary copper excretion",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Baseline laboratory parameter for 24-hour urinary copper excretion."
      },
      {
        "id": "char_13",
        "name": "Non-ceruloplasmin-bound copper (NCC)",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Baseline laboratory parameter for non-ceruloplasmin-bound copper (NCC)."
      },
      {
        "id": "char_14",
        "name": "Medical History",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Medical history coded using MedDRA and summarized by system organ class (SOC) and preferred term (PT)."
      },
      {
        "id": "char_15",
        "name": "Surgical History",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Surgical history coded using MedDRA and summarized by system organ class (SOC) and preferred term (PT)."
      },
      {
        "id": "char_16",
        "name": "Wilson Disease History",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Wilson Disease (WD) history summarized by the number and percentage of participants."
      },
      {
        "id": "char_17",
        "name": "Prior medications for Wilson Disease",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Prior medications used to treat Wilson Disease (WD) summarized by number and percentage of participants."
      }
    ],
    "summary": {
      "populationCount": 7,
      "characteristicCount": 17
    }
  }
}